Rapid Micro Biosystems (RPID) Receivables (2020 - 2026)

Rapid Micro Biosystems (RPID) has 7 years of Receivables data on file, last reported at $6.5 million in Q1 2026.

• For the quarter ending Q1 2026, Receivables rose 43.27% year-over-year to $6.5 million; the trailing twelve-month figure through Mar 2026 stood at $6.5 million (up 43.27% YoY), and the FY2025 full-year result was $3.3 million, down 56.44% from the prior year.
• Receivables grew to $6.5 million in Q1 2026, from $3.3 million in the prior quarter.
• In the past five years, Receivables ranged from a high of $6.5 million in Q1 2026 to a low of $106000.0 in Q4 2024.
• A 5-year average of $4.6 million and a median of $4.7 million in 2022 frame the typical range for Receivables.
• Across the five-year window, Receivables tumbled 98.1% in 2024 and jumped 2992.45% in 2025, its largest moves.
• Tracing RPID's Receivables over 5 years: stood at $5.5 million in 2022, then advanced by 1.86% to $5.6 million in 2023, then plunged by 98.1% to $106000.0 in 2024, then jumped by 2992.45% to $3.3 million in 2025, then surged by 97.86% to $6.5 million in 2026.
• Business Quant data shows RPID's Receivables at $6.5 million in Q1 2026, $3.3 million in Q4 2025, and $5.6 million in Q3 2025.